Active Shortage

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION in Canada?

Yes. METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 125MG has an active shortage reported to Health Canada (last updated February 13, 2020).

Why is METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION be available again?

The estimated resolution date (December 1, 2022) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products · 1 same form & route

Affected strength125MG

Report last updated2020-02-13

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

DEPO-MEDROL

PFIZER CANADA ULC

80MG · DIN 00030767

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

SOLU-MEDROL

PFIZER CANADA ULC

1G · DIN 00036137

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

MEDROL

PFIZER CANADA ULC

16MG · DIN 00036129

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2022-12-01

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02231894

Strength

125MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAMUSCULAR INTRAVENOUS

Active Ingredient

METHYLPREDNISOLONE

Tier

Unrated

Last Updated

2020-02-13

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163